1. Home
  2. STOK vs SHLS Comparison

STOK vs SHLS Comparison

Compare STOK & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$29.35

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Shoals Technologies Group Inc.

SHLS

Shoals Technologies Group Inc.

HOLD

Current Price

$9.30

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
SHLS
Founded
2014
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
STOK
SHLS
Price
$29.35
$9.30
Analyst Decision
Strong Buy
Buy
Analyst Count
10
14
Target Price
$39.20
$9.07
AVG Volume (30 Days)
900.7K
5.7M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
92.73
42.86
EPS
N/A
N/A
Revenue
$184,420,000.00
$475,331,000.00
Revenue This Year
N/A
$26.24
Revenue Next Year
$77.49
$11.52
P/E Ratio
N/A
$41.63
Revenue Growth
404.50
19.07
52 Week Low
$12.25
$4.44
52 Week High
$40.22
$13.18

Technical Indicators

Market Signals
Indicator
STOK
SHLS
Relative Strength Index (RSI) 43.10 43.51
Support Level $28.22 $8.75
Resistance Level $33.51 $9.98
Average True Range (ATR) 1.64 0.71
MACD -0.20 -0.08
Stochastic Oscillator 28.37 0.21

Price Performance

Historical Comparison
STOK
SHLS

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About SHLS Shoals Technologies Group Inc.

Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.

Share on Social Networks: